Physician profile
Ronald Weber
NPI 1902874654
$925.80
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $717 · 2020: $189 · 2022: $19.70.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $212.22 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $113.12 | 2019-2020 | |
| Amarin Pharma, INC. | $100.42 | 2019-2020 | |
| Amgen INC. | $98.60 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $67.52 | 2019-2022 | |
| Phadia US INC. | $51.96 | 2019 | |
| Lilly USA, LLC | $46.16 | 2019 | |
| Endo Pharmaceuticals INC. | $34.38 | 2019 | |
| Pfizer INC. | $31.98 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $21.39 | 2019 | |
| Circassia INC. | $17.61 | 2019 | |
| Genentech USA, INC. | $16.33 | 2019 | |
| Ironshore Pharmaceuticals INC. | $16.13 | 2020 | |
| Shire North American Group INC | $15.98 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $14.86 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $14.60 | 2019 | |
| Hologic Sales and Service, LLC | $14.43 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $12.99 | 2019 | |
| Nabriva Therapeutics, Plc | $12.93 | 2020 | |
| Glaxosmithkline, LLC. | $12.19 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Weber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.